D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$384M |
| 2 |
Apple
AAPL
|
+$377M |
| 3 |
PayPal
PYPL
|
+$368M |
| 4 |
Pfizer
PFE
|
+$339M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$732M |
| 3 |
Netflix
NFLX
|
+$461M |
| 4 |
Citigroup
C
|
+$361M |
| 5 |
Booking.com
BKNG
|
+$288M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.52% |
| 2 | Consumer Discretionary | 9.06% |
| 3 | Financials | 8.14% |
| 4 | Healthcare | 8% |
| 5 | Energy | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
CALL
NextEra Energy
NEE
$187B
| $8.27M | 0.01% |
97,600
-520,700
| -84% | -$41.7M |
|
|
LGAC
1652
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
| $8.25M | 0.01% |
841,617
-29,570
| -3% | -$288K |
|
|
HTPA
1653
DELISTED
Highland Transcend Partners I Corp.
HTPA
| $8.25M | 0.01% |
838,840
+532,685
| +174% | +$5.28M |
|
1654
PUT
ScottsMiracle-Gro
SMG
$4.12B
| $8.23M | 0.01% |
66,900
+36,600
| +121% | +$5.12M |
|
|
DSAC
1655
DELISTED
Duddell Street Acquisition Corp. Class A Ordinary Shares
DSAC
| $8.22M | 0.01% |
827,845
| – | – |
|
|
TPH
1656
DELISTED
Tri Pointe Homes
TPH
| $8.21M | 0.01% |
409,055
-34,212
| -8% | -$795K |
|
|
MBAC
1657
DELISTED
M3-Brigade Acquisition II Corp.
MBAC
| $8.2M | 0.01% |
838,918
+315,416
| +60% | +$3.1M |
|
1658
PUT
Quanta Services
PWR
$87.9B
| $8.19M | 0.01% |
62,200
+17,200
| +38% | +$1.91M |
|
|
IRBT
1659
DELISTED
iRobot
IRBT
| $8.18M | 0.01% |
128,989
+44,718
| +53% | +$2.83M |
|
1660
PUT
CRISPR Therapeutics
CRSP
$4.72B
| $8.16M | 0.01% |
130,000
+60,000
| +86% | +$3.77M |
|
|
TIGR
1661
UP Fintech Holding
TIGR
$861M
| $8.14M | 0.01% |
1,660,525
+1,127,779
| +212% | +$5.06M |
|
|
SWAV
1662
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $8.14M | 0.01% |
39,242
-63,050
| -62% | -$10.4M |
|
1663
CALL
Ovintiv
OVV
$16.3B
| $8.11M | 0.01% |
150,000
-54,900
| -27% | -$2.37M |
|
1664
Calidi Biotherapeutics
CLDI
$1.99M
| $8.11M | 0.01% |
6,831
+33
| +0.5% | +$39K |
|
|
TZPS
1665
DELISTED
TZP Strategies Acquisition Corp. Class A Ordinary Share
TZPS
| $8.1M | 0.01% |
825,709
+508,237
| +160% | +$4.96M |
|
|
FTEV
1666
DELISTED
FinTech Evolution Acquisition Group
FTEV
| $8.1M | 0.01% |
826,302
-263,408
| -24% | -$2.56M |
|
1667
Unisys
UIS
$254M
| $8.09M | 0.01% |
374,456
-92,181
| -20% | -$1.87M |
|
1668
Home BancShares
HOMB
$6.29B
| $8.08M | 0.01% |
357,607
+174,978
| +96% | +$4.14M |
|
1669
CALL
Las Vegas Sands
LVS
$32.1B
| $8.07M | 0.01% |
207,600
-249,300
| -55% | -$10.3M |
|
1670
AAR Corp
AIR
$5.51B
| $8.07M | 0.01% |
166,548
-162,029
| -49% | -$7.01M |
|
1671
Newmark Group
NMRK
$2.89B
| $8.05M | 0.01% |
505,803
+386,761
| +325% | +$6.3M |
|
|
1672
Quanta Services
PWR
$87.9B
| $8.05M | 0.01% |
61,143
-167,722
| -73% | -$18.6M |
|
1673
Carpenter Technology
CRS
$27.8B
| $8.04M | 0.01% |
191,425
+45,701
| +31% | +$1.6M |
|
|
VXRT
1674
DELISTED
Vaxart
VXRT
| $8.03M | 0.01% |
1,592,641
-534,283
| -25% | -$2.71M |
|
|
VMCAU
1675
DELISTED
Valuence Merger Corp. I Unit
VMCAU
| $8.02M | 0.01% |
+800,000
| New | +$8.02M |
|
Similar funds
D.E. Shaw & Co's Q1 2022 Portfolio in Review
As of Q1 2022, D.E. Shaw & Co held 6,280 positions worth $107B, down 11% from $121B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
D.E. Shaw & Co withdrew a net $14.2B in Q1 2022, closing 805 positions and reducing 2,078 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.02B position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, D.E. Shaw & Co opened a new position in Cenovus Energy worth $141M.
- D.E. Shaw & Co's largest Q1 2022 buy was Cenovus Energy: 8,428,527 shares worth $141M.
- D.E. Shaw & Co added most to Starbucks in Q1 2022, an estimated $384M increase.
- D.E. Shaw & Co's biggest Q1 2022 reduction was Netflix, cutting an estimated $461M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2022, selling an estimated $1.02B.
- D.E. Shaw & Co's ten largest holdings make up 9.3% of its $107B portfolio in Q1 2022.
- D.E. Shaw & Co opened 934 new positions and closed 805 in Q1 2022.
- D.E. Shaw & Co's portfolio value fell 11% quarter-over-quarter to $107B.
Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.